Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma.
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
Kelong
K
Han
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
Melanie
M
Ren
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
Wolfgang
W
Wick
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
Lauren
L
Abrey
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
Asha
A
Das
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
Jin
J
Jin
Genentech, South San Francisco, California (K.H., A.D., J.J.); Stanford University, Palo Alto, California (M.R.); University Medical Center & DKFZ, Heidelberg, Germany (W.W.); F. Hoffmann-La Roche, Basel, Switzerland (L.A.); Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (D.A.R.).
David A
DA
Reardon
D005909:Glioblastoma / Q000401:mortality*; D006801:Humans